Ovarian Cancer: ASCO Tumor Boards

This is a case-based activity that includes discussion of a 58-year-old woman who presents with progressive abdominal distention. She has no significant comorbidities, no family history of breast or ovarian cancer, and her initial CA125 is 458 U/mL. The patient had a diagnostic laparoscopy with ascites, peritoneal carcinomatosis involving the omentum, RT diaphragm, and paracolic gutters. Her histology showed high-grade serous cancer. 

Learning Objectives

  • Apply management strategies to patients with advanced-stage high-grade serous cancer of ovarian, fallopian, or peritoneal origin
  • Identify the goals and timing of cytoreductive surgery
  • Evaluate optimal systemic therapy and the role of intraperitoneal chemotherapy
 Continuing Education Credit

1 Credit/Point is available for participation in this course. Certificate and credit types available include:

  • AMA PRA Category 1 Credits™ 
  • ABIM MOC Points
  • Certificate of Participation may be used to confer credit; however, all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits are submitted.
  • Certificate of Completion may be used to document participation, but no credit will be conferred.

Important Notes

  • This course expires on June 22, 2019. Participants must complete all necessary course components by this date.
  • This course is available as part of the 2016 ASCO Tumor Boards bundle.